The Discovery Labs: Joerg Ahlgrimm
The Discovery Labs has appointed Joerg Ahlgrimm - Lonza’s former SVP global operations Pharma/Biotech - as President and Chief Operating Officer.
The Discovery Labs is a holding company which specializes in cell and gene therapy development and manufacturing services, large-scale testing capabilities and real estate services for the life science industry as well as fostering technology innovation.
Ahlgrimm will be responsible for overseeing day-to-day operations at the company. This includes operations for the Center for Breakthrough Medicines (CBM) and Testing Centers of America (TCA) – two core Discovery Labs platform companies (CBM is the largest single-point cell and gene therapy CDMO in the world, while TCA is a large-scale testing company).
As part of his new role, Ahlgrimm is tasked with ensuring the rollout of TCA’s national COVID testing program.
Ahlgrimm brings over 20 years of expertise in pharmaceutical operations, supply chain and manufacturing to The Discovery Labs. Prior to joining the company, Ahlgrimm was head of global operations pharma biotech and nutrition at Lonza. Before Lonza, Ahlgrimm was head of global manufacturing for Baxter Healthcare, BioScience Division/Baxalta Inc, where he led Baxalta’s internal and external manufacturing network as well as plasma collection organization.
